Moody Aldrich Partners LLC Repligen Corp Transaction History

Moody Aldrich Partners LLC

$503 Million
Q3 2024

A detailed history of Moody Aldrich Partners LLC transactions in Repligen Corp stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 1,505 shares of RGEN stock, worth $220,542. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,505

Holding current value

$220,542

% of portfolio

0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$119.79 - $167.35 $180,283 - $251,861	1,505 New	1,505 $223,000
Q1 2024 Apr 29, 2024	SELL	$170.78 - $208.42 $1,024 - $1,250	-6 Reduced 0.5%	1,186 $218,000
Q4 2023 Jan 25, 2024	BUY	$114.17 - $185.35 $136,090 - $220,937	1,192 New	1,192 $214,000
Q1 2023 Apr 27, 2023	SELL	$154.26 - $198.1 $462 - $594	-3 Reduced 0.23%	1,286 $216,000
Q4 2022 Jan 23, 2023	SELL	$162.42 - $220.56 $2,273 - $3,087	-14 Reduced 1.07%	1,289 $0
Q3 2022 Oct 18, 2022	SELL	$160.42 - $256.21 $4.92 Million - $7.85 Million	-30,645 Reduced 95.92%	1,303 $244,000
Q2 2022 Jul 18, 2022	BUY	$140.68 - $188.02 $4.02 Million - $5.38 Million	28,605 Added 855.67%	31,948 $5.19 Million
Q1 2022 May 10, 2022	BUY	$161.19 - $257.96 $211,803 - $338,959	1,314 Added 64.76%	3,343 $629,000
Q4 2021 Feb 02, 2022	SELL	$247.59 - $304.47 $6,684 - $8,220	-27 Reduced 1.31%	2,029 $537,000
Q3 2021 Oct 29, 2021	SELL	$194.77 - $324.21 $194 - $324	-1 Reduced 0.05%	2,056 $594,000
Q2 2021 Aug 04, 2021	SELL	$165.87 - $220.95 $4,976 - $6,628	-30 Reduced 1.44%	2,057 $411,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $60,965 - $76,475	338 Added 19.33%	2,087 $406,000
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $1,776 - $2,478	-12 Reduced 0.68%	1,749 $335,000
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $59,662 - $77,077	-487 Reduced 21.66%	1,761 $260,000
Q2 2020 Jul 30, 2020	SELL	$94.33 - $140.48 $4.46 Million - $6.64 Million	-47,268 Reduced 95.46%	2,248 $278,000
Q1 2020 May 07, 2020	BUY	$84.96 - $109.14 $93,625 - $120,272	1,102 Added 2.28%	49,516 $4.78 Million
Q4 2019 Feb 07, 2020	BUY	$73.84 - $93.08 $423,989 - $534,465	5,742 Added 13.46%	48,414 $4.48 Million
Q3 2019 Nov 12, 2019	BUY	$76.65 - $95.51 $3.27 Million - $4.08 Million	42,672 New	42,672 $3.27 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.13B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Account

Moody Aldrich Partners LLC Repligen Corp Transaction History